البحث عن طبيب

Stephen L. Kopecky, M.D.

  1. Cardiologist
طلب موعد

المنشورات

  1. Sapir OR, Kopecky S, Lopez-Jimenez F. Navigating omega-3s. Eur J Prev Cardiol. 2024 Nov 11; 31 (15):1876-1877
    View PubMed
  2. Brewer LC, Abraham H, Clark D 3rd, Echols M, Hall M, Hodgman K, Kaihoi B, Kopecky S, Krogman A, Leth S, Malik S, Marsteller J, Mathews L, Scales R, Schulte P, Shultz A, Taylor B, Thomas R, Wong N, Olson T. Efficacy and Adherence Rates of a Novel Community-Informed Virtual World-Based Cardiac Rehabilitation Program: Protocol for the Destination Cardiac Rehab Randomized Controlled Trial. J Am Heart Assoc. 2023 Dec 05; 12(23):e030883. Epub 2023 Nov 28.
    View PubMed
  3. Schmidt T, Harmon DM, Kludtke E, Mickow A, Simha V, Kopecky S. Dramatic elevation of LDL cholesterol from ketogenic-dieting: A Case Series. Am J Prev Cardiol. 2023 Jun; 14:100495. Epub 2023 Apr 06.
    View PubMed
  4. Lara-Breitinger KM, Medina Inojosa JR, Li Z, Kunzova S, Lerman A, Kopecky SL, Lopez-Jimenez F. Validation of a Brief Dietary Questionnaire for Use in Clinical Practice: Mini-EAT (Eating Assessment Tool). J Am Heart Assoc. 2023 Jan 3; 12 (1):e025064 Epub 2022 Dec 30
    View PubMed
  5. Nelson DM, Madsen BE, Kopecky SL, Jenson CE, Loth AR, Mullan AF, Clements CM, Lin G. Retrospective validation of acute heart failure risk stratification in the emergency department. Heart Lung. 2023 Jan-Feb; 57:31-40 Epub 2022 Aug 22
    View PubMed
  6. Brewer LC, Abraham H, Kaihoi B, Leth S, Egginton J, Slusser J, Scott C, Penheiter S, Albertie M, Squires R, Thomas R, Scales R, Trejo-Gutierrez J, Kopecky S. A Community-Informed Virtual World-Based Cardiac Rehabilitation Program as an Extension of Center-Based Cardiac Rehabilitation: MIXED-METHODS ANALYSIS OF A MULTICENTER PILOT STUDY. J Cardiopulm Rehabil Prev. 2023 Jan 1; 43 (1):22-30 Epub 2022 July 25
    View PubMed
  7. Kopecky SL, Alias S, Klodas E, Jones PJH. Reduction in Serum LDL Cholesterol Using a Nutrient Compendium in Hyperlipidemic Adults Unable or Unwilling to Use Statin Therapy: A Double-Blind Randomized Crossover Clinical Trial. J Nutr. 2022 Feb 8; 152 (2):458-465
    View PubMed
  8. Lara-Breitinger K, Lynch M, Kopecky S. Nutrition Intervention in Cardiac Rehabilitation: A REVIEW OF THE LITERATURE AND STRATEGIES FOR THE FUTURE. J Cardiopulm Rehabil Prev. 2021 Nov 1; 41 (6):383-388
    View PubMed
  9. Ostfeld RJ, Allen KE, Aspry K, Brandt EJ, Spitz A, Liberman J, Belardo D, O'Keefe JH, Aggarwal M, Miller M, Batiste C, Kopecky S, White B, Shah N, Hawamdeh H, Batts T, Blankstein R, Reddy K, Ornish D, Freeman AM. Vasculogenic Erectile Dysfunction: The Impact of Diet and Lifestyle. Am J Med. 2021 Mar; 134 (3):310-316 Epub 2020 Nov 20
    View PubMed
  10. Jackson CL, Deng Y, Yao X, Van Houten H, Shah ND, Kopecky S. Proprotein convertase subtilisin/kexin type 9 inhibitor utilization and low-density lipoprotein-cholesterol control in familial hypercholesterolemia. J Clin Lipidol. 2021 Mar-Apr; 15 (2):339-346 Epub 2020 Dec 27
    View PubMed
  11. Meeusen JW, Donato LJ, Kopecky SL, Vasile VC, Jaffe AS, Laaksonen R. Ceramides improve atherosclerotic cardiovascular disease risk assessment beyond standard risk factors. Clin Chim Acta. 2020 Dec; 511:138-142 Epub 2020 Oct 12
    View PubMed
  12. Triplett J, Kassardjian CD, Liewluck T, Tahir A, Lennon V, Kopecky S, Milone M. Cardiac and Respiratory Complications of Necrotizing Autoimmune Myopathy. Mayo Clin Proc. 2020 Oct; 95 (10):2144-2149 Epub 2020 Aug 14
    View PubMed
  13. Oren O, Kopecky SL, Blumenthal RS, Gersh BJ, Yang EH. Cardiovascular Prevention in Individuals at High Risk of Developing Cancer. JACC CardioOncol. 2020 Sep; 2 (3):527-531 Epub 2020 Sept 15
    View PubMed
  14. Ye Q, Svatikova A, Meeusen JW, Kludtke EL, Kopecky SL. Effect of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors on Plasma Ceramide Levels. Am J Cardiol. 2020 Aug 1; 128:163-167 Epub 2020 May 15
    View PubMed
  15. Bangash H, Pencille L, Gundelach JH, Makkawy A, Sutton J, Makkawy L, Dikilitas O, Kopecky S, Freimuth R, Caraballo PJ, Kullo IJ. An Implementation Science Framework to Develop a Clinical Decision Support Tool for Familial Hypercholesterolemia. J Pers Med. 2020 Jul 23; 10(3).
    View PubMed
  16. Kumar P, Kopecky SL, Yang EH, Oren O. Clonal Hematopoiesis of Indeterminate Potential and Cardiovascular Disease. Curr Oncol Rep. 2020 Jul 9; 22 (9):87 Epub 2020 July 09
    View PubMed
  17. Wyatt KD, Poole LR, Mullan AF, Kopecky SL, Heaton HA. Clinical evaluation and diagnostic yield following evaluation of abnormal pulse detected using Apple Watch. J Am Med Inform Assoc. 2020 Jul 1; 27 (9):1359-1363
    View PubMed
  18. Oren O, Yang EH, Molina JR, Bailey KR, Blumenthal RS, Kopecky SL. Cardiovascular Health and Outcomes in Cancer Patients Receiving Immune Checkpoint Inhibitors. Am J Cardiol. 2020 Jun 15; 125 (12):1920-1926 Epub 2020 Mar 05
    View PubMed
  19. Svatikova A, Kopecky SL. Why and How Cardiovascular Screening Should Be Implemented in Sexual Medicine Practice: Erectile Dysfunction and Cardiovascular Disease. J Sex Med. 2020 Jun; 17 (6):1045-1048 Epub 2020 Apr 04
    View PubMed
  20. Zhang X, Zhou B, Kopecky SL, Trost LW. Two dimensional penile ultrasound vibro-elastography for measuring penile tissue viscoelasticity: A pilot patient study and its correlation with penile ultrasonography. J Mech Behav Biomed Mater. 2020 Mar; 103:103570 Epub 2019 Nov 30
    View PubMed
  21. McCabe PJ, Sendin MJ, Stuart-Mullen L, Kronebusch B, Fowler S, Krecke C, Kopecky S. Initial Psychometric Testing of the Knowledge About Atrial Fibrillation and Self-Management Survey. J Cardiovasc Nurs. 2020 Jan/Feb; 35 (1):35-44
    View PubMed
  22. Oren O, Kludtke EL, Kopecky SL. Characteristics and Outcomes of Patients Treated With Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors (The Mayo Clinic Experience). Am J Cardiol. 2019 Dec 1; 124 (11):1669-1673
    View PubMed
  23. Kermott CA, Schroeder DR, Kopecky SL, Behrenbeck TR. Cardiorespiratory Fitness and Coronary Artery Calcification in a Primary Prevention Population. Mayo Clin Proc Innov Qual Outcomes. 2019 Jun; 3 (2):122-130 Epub 2019 May 27
    View PubMed
  24. Cardoso R, Blumenthal RS, Kopecky S, Lopez-Jimenez F, Martin SS. How Low to Go With Lipid-Lowering Therapies in a Cost-effective and Prudent Manner. Mayo Clin Proc. 2019 Apr; 94 (4):660-669 Epub 2019 Feb 06
    View PubMed
  25. Brum J, Ramsey D, McRorie J, Bauer B, Kopecky SL. Meta-Analysis of Usefulness of Psyllium Fiber as Adjuvant Antilipid Therapy to Enhance Cholesterol Lowering Efficacy of Statins. Am J Cardiol. 2018 Oct 1; 122 (7):1169-1174 Epub 2018 July 04
    View PubMed
  26. Otvos JD, Guyton JR, Connelly MA, Akapame S, Bittner V, Kopecky SL, Lacy M, Marcovina SM, Muhlestein JB, Boden WE. Relations of GlycA and lipoprotein particle subspecies with cardiovascular events and mortality: A post hoc analysis of the AIM-HIGH trial. J Clin Lipidol. 2018 Mar - Apr; 12 (2):348-355.e2 Epub 2018 Jan 12
    View PubMed
  27. V Willrich MA, Kaleta EJ, Bryant SC, Spears GM, Train LJ, Peterson SE, Lennon VA, Kopecky SL, Baudhuin LM. Genetic variation in statin intolerance and a possible protective role for UGT1A1. Pharmacogenomics. 2018 Jan; 19 (2):83-94 Epub 2017 Dec 06
    View PubMed
  28. Hussain N, Gersh BJ, Gonzalez Carta K, Sydo N, Lopez-Jimenez F, Kopecky SL, Thomas RJ, Asirvatham SJ, Allison TG. Impact of Cardiorespiratory Fitness on Frequency of Atrial Fibrillation, Stroke, and All-Cause Mortality. Am J Cardiol. 2018 Jan 1; 121 (1):41-49 Epub 2017 Nov 13
    View PubMed
  29. Van't Hof JR, Duval S, Walts A, Kopecky SL, Luepker RV, Hirsch AT. Contemporary Primary Prevention Aspirin Use by Cardiovascular Disease Risk: Impact of US Preventive Services Task Force Recommendations, 2007-2015: A Serial, Cross-sectional Study. J Am Heart Assoc. 2017 Oct 3; 6 (10) Epub 2017 Oct 03
    View PubMed
  30. Svatikova A, Kopecky SL. Cholesterol Management in the Era of PCSK9 Inhibitors. Curr Cardiol Rep. 2017 Sep; 19 (9):83
    View PubMed
  31. Chamberlain AM, Gersh BJ, Alonso A, Kopecky SL, Killian JM, Weston SA, Roger VL. No decline in the risk of heart failure after incident atrial fibrillation: A community study assessing trends overall and by ejection fraction. Heart Rhythm. 2017 Jun; 14 (6):791-798 Epub 2017 Jan 21
    View PubMed
  32. Le RJ, Cullen MW, Lahr BD, Wright RS, Kopecky SL. Side Effects of CV Medications Following Hospitalization for ACS Are Associated With More Frequent Health-Care Contacts. J Cardiovasc Pharmacol Ther. 2017 May; 22 (3):250-255 Epub 2016 Oct 02
    View PubMed
  33. Cheungpasitporn W, Kopecky SL, Specks U, Bharucha K, Fervenza FC. Non-ischemic cardiomyopathy after rituximab treatment for membranous nephropathy. J Renal Inj Prev. 2017; 6 (1):18-25 Epub 2016 Nov 02
    View PubMed
  34. Brewer LC, Kaihoi B, Schaepe K, Zarling K, Squires RW, Thomas RJ, Kopecky S. Patient-perceived acceptability of a virtual world-based cardiac rehabilitation program. Digit Health. 2017 Jan-Dec; 3:2055207617705548 Epub 2017 Apr 24
    View PubMed
  35. Kopecky SL, Bauer DC, Gulati M, Nieves JW, Singer AJ, Toth PP, Underberg JA, Wallace TC, Weaver CM. Lack of Evidence Linking Calcium With or Without Vitamin D Supplementation to Cardiovascular Disease in Generally Healthy Adults: A Clinical Guideline From the National Osteoporosis Foundation and the American Society for Preventive Cardiology. Ann Intern Med. 2016 Dec 20; 165 (12):867-868 Epub 2016 Oct 25
    View PubMed
  36. Morris JR, Bellolio MF, Sangaralingham LR, Schilz SR, Shah ND, Goyal DG, Bell MR, Kopecky SL, Gilani WI, Hess EP. Comparative Trends and Downstream Outcomes of Coronary Computed Tomography Angiography and Cardiac Stress Testing in Emergency Department Patients With Chest Pain: An Administrative Claims Analysis. Acad Emerg Med. 2016 Sep; 23 (9):1022-30 Epub 2016 Sept 07
    View PubMed
  37. Kloner RA, Carson C 3rd, Dobs A, Kopecky S, Mohler ER 3rd. Testosterone and Cardiovascular Disease. J Am Coll Cardiol. 2016 Feb 9; 67 (5):545-57
    View PubMed
  38. Bellew SD, Bremer ML, Kopecky SL, Lohse CM, Munger TM, Robelia PM, Smars PA. Impact of an Emergency Department Observation Unit Management Algorithm for Atrial Fibrillation. J Am Heart Assoc. 2016 Feb 8; 5 (2) Epub 2016 Feb 08
    View PubMed
  39. Kopecky SL, Bauer DC, Gulati M, Nieves JW, Singer AJ, Toth PP, Underberg JA, Wallace TC, Weaver CM. Lack of evidence linking calcium with or without Vitamin D supplementation to cardiovascular disease in generally healthy adults: A clinical guideline from the national osteoporosis foundation and the American Society for Preventive Cardiology Annals of Internal Medicine. 2016; 165: (12)867-8.
  40. Moriarty PM, Thompson PD, Cannon CP, Guyton JR, Bergeron J, Zieve FJ, Bruckert E, Jacobson TA, Kopecky SL, Baccara-Dinet MT, Du Y, Pordy R, Gipe DA, ODYSSEY ALTERNATIVE Investigators. Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trial. J Clin Lipidol. 2015 Nov-Dec; 9 (6):758-769 Epub 2015 Aug 29
    View PubMed
  41. Cainzos-Achirica M, Desai CS, Wang L, Blaha MJ, Lopez-Jimenez F, Kopecky SL, Blumenthal RS, Martin SS. Pathways Forward in Cardiovascular Disease Prevention One and a Half Years After Publication of the 2013 ACC/AHA Cardiovascular Disease Prevention Guidelines. Mayo Clin Proc. 2015 Sep; 90 (9):1262-71 Epub 2015 Aug 11
    View PubMed
  42. Kopecky S, Baum S, Foody JM, Koren M, McKenney J, Sperling L, Wong ND, Statin Intolerance Roundtable Participants. Insights Into Statin Intolerance. Clin Cardiol. 2015 Sep; 38 (9):520-6 Epub 2015 Sept 03
    View PubMed
  43. Ruzek L, Konecny T, Soucek F, Konecny D, Mach L, Ommen SR, Kopecky SL, Nishimura RA. Phosphodiesterase 5 Inhibitor Use in Men With Hypertrophic Cardiomyopathy. Am J Cardiol. 2015 Aug 15; 116(4):618-21. Epub 2015 May 21.
    View PubMed
  44. Brewer LC, Kaihoi B, Zarling KK, Squires RW, Thomas R, Kopecky S. The use of virtual world-based cardiac rehabilitation to encourage healthy lifestyle choices among cardiac patients: intervention development and pilot study protocol. JMIR Res Protoc. 2015 Apr 08; 4(2):e39.
    View PubMed
  45. Robelia P, Kopecky S, Thacher T. Atrial fibrillation care improvement collaborative. BMJ Qual Improv Rep. 2015; 4 (1) Epub 2015 Sept 02
    View PubMed
  46. Nigam A, Talajic M, Roy D, Nattel S, Lambert J, Nozza A, Jones P, Ramprasath VR, O'Hara G, Kopecky S, Brophy JM, Tardif JC, AFFORD Investigators. Fish oil for the reduction of atrial fibrillation recurrence, inflammation, and oxidative stress. J Am Coll Cardiol. 2014 Oct 7; 64 (14):1441-8
    View PubMed
  47. Kullo IJ, Trejo-Gutierrez JF, Lopez-Jimenez F, Thomas RJ, Allison TG, Mulvagh SL, Arruda-Olson AM, Hayes SN, Pollak AW, Kopecky SL, Hurst RT. A perspective on the New American College of Cardiology/American Heart Association guidelines for cardiovascular risk assessment. Mayo Clin Proc. 2014 Sep; 89 (9):1244-56 Epub 2014 Aug 12
    View PubMed
  48. Lopez-Jimenez F, Simha V, Thomas RJ, Allison TG, Basu A, Fernandes R, Hurst RT, Kopecky SL, Kullo IJ, Mulvagh SL, Thompson WG, Trejo-Gutierrez JF, Wright RS. A summary and critical assessment of the 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: filling the gaps. Mayo Clin Proc. 2014 Sep; 89 (9):1257-78 Epub 2014 Aug 12
    View PubMed
  49. Dhoble A, Lahr BD, Allison TG, Bailey KR, Thomas RJ, Lopez-Jimenez F, Kullo IJ, Gupta B, Kopecky SL. Predicting long-term cardiovascular risk using the mayo clinic cardiovascular risk score in a referral population. Am J Cardiol. 2014 Sep 1; 114(5):704-10. Epub 2014 Jun 19
    View PubMed
  50. Thaden JJ, McCully RB, Kopecky SL, Allison TG. Echocardiographic determinants of peak aerobic capacity and breathing efficiency in patients with undifferentiated dyspnea. Am J Cardiol. 2014 Aug 1; 114 (3):473-8 Epub 2014 May 17
    View PubMed
  51. Dhoble A, Enriquez-Sarano M, Kopecky SL, Abdelmoneim SS, Cruz P, Thomas RJ, Allison TG. Cardiopulmonary responses to exercise and its utility in patients with aortic stenosis. Am J Cardiol. 2014 May 15; 113 (10):1711-6 Epub 2014 Mar 02
    View PubMed
  52. Rosenson RS, Baker SK, Jacobson TA, Kopecky SL, Parker BA. An assessment by the Statin Muscle Safety Task Force: 2014 update. J Clin Lipidol. 2014 May-Jun; 8 (3 Suppl):S58-71
    View PubMed
  53. Fenstad ER, Anavekar NS, Williamson E, Deschamps C, Kopecky SL. Twist and shout: acute right ventricular failure secondary to cardiac herniation and pulmonary artery compression. Circulation. 2014 Apr 1; 129 (13):e409-12
    View PubMed
  54. Dhoble A, Lahr BD, Allison TG, Kopecky SL. Cardiopulmonary fitness and heart rate recovery as predictors of mortality in a referral population. J Am Heart Assoc. 2014 Mar 24; 3 (2):e000559
    View PubMed
  55. Abudiab M, Aijaz B, Konecny T, Kopecky SL, Squires RW, Thomas RJ, Allison TG. Use of functional aerobic capacity based on stress testing to predict outcomes in normal, overweight, and obese patients. Mayo Clin Proc. 2013 Dec; 88(12):1427-34.
    View PubMed
  56. Killu AM, Wright RS, Kopecky SL. Questions and answers on proper peri-operative management of antiplatelet therapy after coronary stent implantation to prevent stent thrombosis. Am J Cardiol. 2013 Oct 1; 112(7):1046-50. Epub 2013 Jul 25.
    View PubMed
  57. Zysek V, Spoon J, Kopecky S. Mayo Clinic: Management of patients with statin intolerance. Clinical Lipidology. 2013; 8(5):541-9.
  58. Konecny T, Nehra A, Pellikka PA, Ommen SR, Kopecky SL. Stress imaging in men with hypertrophic cardiomyopathy and erectile dysfunction. Journal of Men's Health. 2013; 10(4):152-3.
  59. Heaney RP, Kopecky S, Maki KC, Hathcock J, Mackay D, Wallace TC. A review of calcium supplements and cardiovascular disease risk. Adv Nutr. 2012 Nov; 3(6):763-71. Epub 2012 Nov 01.
    View PubMed
  60. Kopecky S. New anticoagulants for stroke prophylaxis in atrial fibrillation: assessing the impact on medication adherence. Am J Cardiovasc Drugs. 2012 Oct 1; 12 (5):287-94
    View PubMed
  61. Dhoble A, Sarano ME, Kopecky SL, Thomas RJ, Hayes CL, Allison TG. Safety of symptom-limited cardiopulmonary exercise testing in patients with aortic stenosis. Am J Med. 2012 Jul; 125(7):704-8. Epub 2012 May 03.
    View PubMed
  62. Gupta B, Kopecky SL. Childhood obesity: Implication for adult health behaviors The Global Journal of Health and Physical Education Pedagogy. 2012; 1:2-14.
  63. Gupta BP, Murad MH, Clifton MM, Prokop L, Nehra A, Kopecky SL. The effect of lifestyle modification and cardiovascular risk factor reduction on erectile dysfunction: a systematic review and meta-analysis. Arch Intern Med. 2011 Nov 14; 171 (20):1797-803 Epub 2011 Sept 12
    View PubMed
  64. Vickers KS, Nies MA, Dierkhising RA, Salandy SW, Jumean M, Squires RW, Thomas RJ, Kopecky SL. Exercise DVD improves exercise expectations in cardiovascular outpatients. Am J Health Behav. 2011 May; 35 (3):305-17
    View PubMed
  65. Cullen MW, Reeder GS, Farkouh ME, Kopecky SL, Smars PA, Behrenbeck TR, Allison TG. Outcomes in patients with chest pain evaluated in a chest pain unit: the chest pain evaluation in the emergency room study cohort. Am Heart J. 2011 May; 161(5):871-7.
    View PubMed
  66. Kopecky SL, Litin SC. Clinical pearls in cardiology. Mayo Clin Proc. 2010 May; 85 (5):473-8
    View PubMed
  67. Al Badarin FJ, Kullo IJ, Kopecky SL, Thomas RJ. Impact of ezetimibe on atherosclerosis: is the jury still out? Mayo Clin Proc. 2009 Apr; 84 (4):353-61
    View PubMed
  68. Aijaz B, Babuin L, Squires RW, Kopecky SL, Johnson BD, Thomas RJ, Allison TG. Long-term mortality with multiple treadmill exercise test abnormalities: comparison between patients with and without cardiovascular disease. Am Heart J. 2008 Oct; 156(4):783-9. Epub 2008 Jul 11.
    View PubMed
  69. Jahangir A, Lee V, Friedman PA, Trusty JM, Hodge DO, Kopecky SL, Packer DL, Hammill SC, Shen WK, Gersh BJ. Long-term progression and outcomes with aging in patients with lone atrial fibrillation: a 30-year follow-up study. Circulation. 2007 Jun 19; 115 (24):3050-6 Epub 2007 June 04
    View PubMed
  70. Powell BD, Bybee KA, Valeti U, Thomas RJ, Kopecky SL, Mullany CJ, Wright RS. Influence of preoperative lipid-lowering therapy on postoperative outcome in patients undergoing coronary artery bypass grafting. Am J Cardiol. 2007 Mar 15; 99(6):785-9. Epub 2007 Jan 18.
    View PubMed
  71. Erbel C, Sato K, Meyer FB, Kopecky SL, Frye RL, Goronzy JJ, Weyand CM. Functional profile of activated dendritic cells in unstable atherosclerotic plaque. Basic Res Cardiol. 2007 Mar; 102(2):123-32. Epub 2006 Dec 01.
    View PubMed
  72. Atar D, Huber K, Rupprecht HJ, Kopecky SL, Schwitter J, Theek C, Brandl K, Henning R, Geudelin B. Rationale and design of the 'F.I.R.E.' study. A multicenter, double-blind, randomized, placebo-controlled study to measure the effect of FX06 (a fibrin-derived peptide Bbeta(15-42)) on ischemia-reperfusion injury in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. Cardiology. 2007; 108(2):117-23. Epub 2006 Oct 02.
    View PubMed
  73. Kopecky SL. Effect of beta blockers, particularly carvedilol, on reducing the risk of events after acute myocardial infarction. Am J Cardiol. 2006 Oct 15; 98 (8):1115-9 Epub 2006 Aug 31
    View PubMed
  74. Nigam A, Wright RS, Allison TG, Williams BA, Kopecky SL, Reeder GS, Murphy JG, Jaffe AS. Excess weight at time of presentation of myocardial infarction is associated with lower initial mortality risks but higher long-term risks including recurrent re-infarction and cardiac death. Int J Cardiol. 2006 Jun 16; 110 (2):153-9 Epub 2005 July 25
    View PubMed
  75. Rodgers GP, Kopecky S. The future of cardiovascular biomarkers. Am Heart Hosp J. 2006 Summer; 4(3):228-31.
    View PubMed
  76. Benson H, Dusek JA, Sherwood JB, Lam P, Bethea CF, Carpenter W, Levitsky S, Hill PC, Clem DW, Jain MK, Drumel D, Kopecky SL, Mueller PS, Marek D, Rollins S, Hibberd PL. Study of the Therapeutic Effects of Intercessory Prayer (STEP) in cardiac bypass patients: a multicenter randomized trial of uncertainty and certainty of receiving intercessory prayer. Am Heart J. 2006 Apr; 151(4):934-42.
    View PubMed
  77. Zhang X, Niessner A, Nakajima T, Ma-Krupa W, Kopecky SL, Frye RL, Goronzy JJ, Weyand CM. Interleukin 12 induces T-cell recruitment into the atherosclerotic plaque. Circ Res. 2006 Mar 3; 98(4):524-31. Epub 2006 Jan 19.
    View PubMed
  78. Sato K, Niessner A, Kopecky SL, Frye RL, Goronzy JJ, Weyand CM. TRAIL-expressing T cells induce apoptosis of vascular smooth muscle cells in the atherosclerotic plaque. J Exp Med. 2006 Jan 23; 203(1):239-50. Epub 2006 Jan 17.
    View PubMed
  79. Osranek M, Bursi F, Bailey KR, Grossardt BR, Brown RD Jr, Kopecky SL, Tsang TS, Seward JB. Left atrial volume predicts cardiovascular events in patients originally diagnosed with lone atrial fibrillation: three-decade follow-up. Eur Heart J. 2005 Dec; 26: (23)2556-61.
    View PubMed
  80. Camilleri M, Gamble GL, Kopecky SL, Wood MB, Hockema ML. Principles and process in the development of the Mayo Clinic's individual and institutional conflict of interest policy. Mayo Clin Proc. 2005 Oct; 80(10):1340-6.
    View PubMed
  81. Bybee KA, Powell BD, Valeti U, Rosales AG, Kopecky SL, Mullany C, Wright RS. Preoperative aspirin therapy is associated with improved postoperative outcomes in patients undergoing coronary artery bypass grafting. Circulation. 2005 Aug 30; 112 (9 Suppl):I286-92
    View PubMed
  82. Warrington KJ, Kent PD, Frye RL, Lymp JF, Kopecky SL, Goronzy JJ, Weyand CM. Rheumatoid arthritis is an independent risk factor for multi-vessel coronary artery disease: a case control study. Arthritis Res Ther. 2005; 7 (5):R984-91 Epub 2005 June 29
    View PubMed
  83. Bybee KA, Kopecky SL, Williams BA, Murphy JG, Wright RS. Reduced creatine kinase release with statin use at the time of myocardial infarction. Int J Cardiol. 2004 Sep; 96(3):461-6.
    View PubMed
  84. Bybee KA, Powell BD, Williams BA, Murphy JG, Kopecky SL, Wright RS. Superior short-term cholesterol control and achievement of the adult treatment panel III low-density lipoprotein goals with initiation of statin therapy by the time of hospital discharge following acute myocardial infarction. Am J Cardiol. 2004 Mar 15; 93(6):776-9.
    View PubMed
  85. Lymp JF, Kopecky SL. Interim monitoring: ensuring safety and efficacy in clinical trials. Clinical Researcher. 2004 Mar; 2(3):14-7.
  86. Brilakis ES, Wright RS, Kopecky SL, Mavrogiorgos NC, Reeder GS, Rihal CS, Gersh BJ, Williams BA, Clements IP. Association of the PURSUIT risk score with predischarge ejection fraction, angiographic severity of coronary artery disease, and mortality in a nonselected, community-based population with non-ST-elevation acute myocardial infarction. Am Heart J. 2003 Nov; 146 (5):811-8
    View PubMed
  87. Peters RJG, Mehta SR, Fox KAA, Zhao F, Lewis BS, Kopecky SL, Diaz R, Commerford PJ, Valentin V, Yusuf S. Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes - Observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study. Circulation. 2003 Oct 7; 108(14):1682-7.
    View PubMed
  88. Kopecky SL, Jopke T. The state of the clinical trials system today. Minn Med. 2003 Oct; 86(10):28-33.
    View PubMed
  89. Tedesco JV, Williams BA, Wright RS, Reeder GS, Dvorak D, Kopecky SL, Miller WL, Coronary Care Unit Group. Baseline comorbidities and treatment strategy in elderly patients are associated with outcome of cardiogenic shock in a community-based population. Am Heart J. 2003 Sep; 146(3):472-8.
    View PubMed
  90. Nakajima T, Goek O, Zhang X, Kopecky SL, Frye RL, Goronzy JJ, Weyand CM. De novo expression of killer immunoglobulin-like receptors and signaling proteins regulates the cytotoxic function of CD4 T cells in acute coronary syndromes. Circ Res. 2003 Jul 25; 93 (2):106-13 Epub 2003 June 19
    View PubMed
  91. Kopecky SL, Aviles RJ, Bell MR, Lobl JK, Tipping D, Frommell G, Ramsey K, Holland AE, Midei M, Jain A, Kellett M, Gibbons RJ, AmP579 Delivery for Myocardial Infarction REduction study. A randomized, double-blinded, placebo-controlled, dose-ranging study measuring the effect of an adenosine agonist on infarct size reduction in patients undergoing primary percutaneous transluminal coronary angioplasty: the ADMIRE (AmP579 Delivery for Myocardial Infarction REduction) study. Am Heart J. 2003 Jul; 146: (1)146-52.
    View PubMed
  92. Gami AS, Wright RS, Ballman KV, Kopecky SL, Hayes SN. Hormone replacement therapy and risk of acute myocardial infarction in postmenopausal women with diabetes mellitus. Am J Cardiol. 2003 May 15; 91(10):1275-7.
    View PubMed
  93. Tedesco JV, Wright RS, Williams BA, Kopecky SL, Dvorak DL, Reeder GS, Miller WL, Mayo Coronary Care Unit Group. Effect of diabetes on the mortality risk of cardiogenic shock in a community-based population. Mayo Clin Proc. 2003 May; 78 (5):561-6
    View PubMed
  94. Decker WW, Prina LD, Smars PA, Boggust AJ, Zinsmeister AR, Kopecky SL. Continuous 12-lead electrocardiographic monitoring in an emergency department chest pain unit: an assessment of potential clinical effect. Ann Emerg Med. 2003 Mar; 41 (3):342-51
    View PubMed
  95. Murphy J, Wright RS, Gussak I, Williams B, Daly RN, Cain VA, Pieniaszek HJ, Sy SK, Ebling W, Simonson K, Wilcox RA, Kopecky SL. The use of roxifiban (DMP754), a novel oral platelet glycoprotein IIb/IIIa receptor inhibitor, in patients with stable coronary artery disease. Am J Cardiovasc Drugs. 2003; 3 (2):101-12
    View PubMed
  96. Gumina RJ, Wright RS, Kopecky SL, Miller WL, Williams BA, Reeder GS, Murphy JG. Strong predictive value of TIMI risk score analysis for in-hospital and long-term survival of patients with right ventricular infarction. Eur Heart J. 2002 Nov; 23 (21):1678-83
    View PubMed
  97. Aviles RJ, Wright RS, Aviles JM, McDonald F, Ballman K, Harker-Murray A, Scott C, Lauer MS, Kopecky SL, Jaffe AS. Long-term prognosis of patients with clinical unstable angina pectoris without elevation of creatine kinase but with elevation of cardiac troponin i levels. Am J Cardiol. 2002 Oct 15; 90 (8):875-8
    View PubMed
  98. Wright RS, Reeder GS, Herzog CA, Albright RC, Williams BA, Dvorak DL, Miller WL, Murphy JG, Kopecky SL, Jaffe AS. Acute myocardial infarction and renal dysfunction: a high-risk combination. Ann Intern Med. 2002 Oct 1; 137 (7):563-70
    View PubMed
  99. Wright RS, Murphy JG, Bybee KA, Kopecky SL, LaBlanche JM. Statin lipid-lowering therapy for acute myocardial infarction and unstable angina: efficacy and mechanism of benefit. Mayo Clin Proc. 2002 Oct; 77(10):1085-92.
    View PubMed
  100. Bybee KA, Wright RS, Kopecky SL. Effect of early statin therapy after acute coronary syndromes: a concise review of the recent data. Cardiol Rev. 2002 Sep-Oct; 10 (5):301-5
    View PubMed
  101. Brilakis ES, Mavrogiorgos NC, Kopecky SL, Rihal CC, Gersh BJ, Williams BA, Clements IP. Usefulness of QRS duration in the absence of bundle branch block as an early predictor of survival in non-ST elevation acute myocardial infarction. Am J Cardiol. 2002 May 1; 89 (9):1013-8
    View PubMed
  102. Dusek JA, Sherwood JB, Friedman R, Myers P, Bethea CF, Levitsky S, Hill PC, Jain MK, Kopecky SL, Mueller PS, Lam P, Benson H, Hibberd PL. Study of the Therapeutic Effects of Intercessory Prayer (STEP): study design and research methods. Am Heart J. 2002 Apr; 143(4):577-84.
    View PubMed
  103. Nakajima T, Schulte S, Warrington KJ, Kopecky SL, Frye RL, Goronzy JJ, Weyand CM. T-cell-mediated lysis of endothelial cells in acute coronary syndromes. Circulation. 2002 Feb 5; 105 (5):570-5
    View PubMed
  104. Holland AE, Wright RS, Kopecky SL. Educating Investigative Sites: Bridging the Knowledge Gap in Clinical Trials. Clinical Researcher. 2002; 2(6):14-8.
  105. Nigam A, Kopecky SL. Therapeutic potential of monoclonal antibodies in myocardial reperfusion injury. Am J Cardiovasc Drugs. 2002; 2 (6):367-76
    View PubMed
  106. Aviles JM, Whelan SE, Hernke DA, Williams BA, Kenny KE, O'Fallon WM, Kopecky SL. Intercessory prayer and cardiovascular disease progression in a coronary care unit population: a randomized controlled trial. Mayo Clin Proc. 2001 Dec; 76 (12):1192-8
    View PubMed
  107. Mathew V, Farkouh ME, Gersh BJ, Rihal CS, Reeder GS, Grill DE, Urban LH, Kopecky SL, Chesebro JH, Holmes DR. Early coronary angiography improves long-term survival in unstable angina. Am Heart J. 2001 Nov; 142: (5)768-74.
    View PubMed
  108. Weyand CM, Goronzy JJ, Liuzzo G, Kopecky SL, Holmes DR Jr, Frye RL. T-cell immunity in acute coronary syndromes. Mayo Clin Proc. 2001 Oct; 76 (10):1011-20
    View PubMed
  109. Wright RS, Kopecky SL, Timm M, Pflaum DD, Carr C, Evers K, Bell J, Wabasha Heart Attack Team. Impact of community-based education on health care evaluation in patients with acute chest pain syndromes: the Wabasha Heart Attack Team (WHAT) project. Fam Pract. 2001 Oct; 18 (5):537-9
    View PubMed
  110. Rusnak JM, Kopecky SL, Clements IP, Gibbons RJ, Holland AE, Peterman HS, Martin JS, Saoud JB, Feldman RL, Breisblatt WM, Simons M, Gessler CJ, Yu AS. An anti-CD11/CD18 monoclonal antibody in patients with acute myocardial infarction having percutaneous transluminal coronary angioplasty (the FESTIVAL study). Am J Cardiol. 2001 Sep 1; 88(5):482-7.
    View PubMed
  111. O'Connor CM, Gattis WA, Hellkamp AS, Langer A, Larsen RL, Harrington RA, Berkowitz SD, O'Gara PT, Kopecky SL, Gheorghiade M, Daly R, Califf RM, Fuster V. Comparison of two aspirin doses on ischemic stroke in post-myocardial infarction patients in the warfarin (Coumadin) Aspirin Reinfarction Study (CARS). Am J Cardiol. 2001 Sep 1; 88(5):541-6.
    View PubMed
  112. Brilakis ES, Wright RS, Kopecky SL, Reeder GS, Williams BA, Miller WL. Bundle branch block as a predictor of long-term survival after acute myocardial infarction. Am J Cardiol. 2001 Aug 1; 88 (3):205-9
    View PubMed
  113. Suwaidi JA, Wright RS, Grill JP, Hensrud DD, Murphy JG, Squires RW, Kopecky SL. Obesity is associated with premature occurrence of acute myocardial infarction. Clin Cardiol. 2001 Aug; 24 (8):542-7
    View PubMed
  114. Alexander KP, Newby LK, Hellkamp AS, Harrington RA, Peterson ED, Kopecky S, Langer A, O'Gara P, O'Connor CM, Daly RN, Califf RM, Khan S, Fuster V. Initiation of hormone replacement therapy after acute myocardial infarction is associated with more cardiac events during follow-up. J Am Coll Cardiol. 2001 Jul; 38(1):1-7.
    View PubMed
  115. Al-Khatib SM, Pieper KS, Lee KL, Mahaffey KW, Hochman JS, Pepine CJ, Kopecky SL, Akkerhuis M, Stepinska J, Simoons ML, Topol EJ, Califf RM, Harrington RA. Atrial fibrillation and mortality among patients with acute coronary syndromes without ST-segment elevation: results from the PURSUIT trial. Am J Cardiol. 2001 Jul 1; 88(1):A7, 76-9.
    View PubMed
  116. Sgura FA, Wright RS, Kopecky SL, Grill JP, Reeder GS. Length of stay in myocardial infarction. Cost Qual. 2001 Jun; 12-20, 25
    View PubMed
  117. Miller WL, Sgura FA, Kopecky SL, Asirvatham SJ, Williams BA, Wright RS, Reeder GS. Characteristics of presenting electrocardiograms of acute myocardial infarction from a community-based population predict short- and long-term mortality. Am J Cardiol. 2001 May 1; 87 (9):1045-50
    View PubMed
  118. Liuzzo G, Vallejo AN, Kopecky SL, Frye RL, Holmes DR, Holmes DR, Goronzy JJ, Weyand CM. Molecular fingerprint of interferon-gamma signaling in unstable angina. Circulation. 2001 Mar 20; 103 (11):1509-14
    View PubMed
  119. Bybee KA, Wright RS, Williams BA, Murphy JG, Holmes DR Jr, Holmes DR Jr, Kopecky SL. Effect of concomitant or very early statin administration on in-hospital mortality and reinfarction in patients with acute myocardial infarction. Am J Cardiol. 2001 Mar 15; 87 (6):771-4, A7
    View PubMed
  120. Wright RS, Kopecky SL, Reeder GS. Update on intravenous fibrinolytic therapy for acute myocardial infarction. Mayo Clin Proc. 2000 Nov; 75 (11):1185-91; quiz 1192
    View PubMed
  121. Miller WL, Wright RS, Grill JP, Kopecky SL. Improved survival after acute myocardial infarction in patients with advanced Killip class. Clin Cardiol. 2000 Oct; 23 (10):751-8
    View PubMed
  122. Lincoff AM, Harrington RA, Califf RM, Hochman JS, Guerci AD, Ohman EM, Pepine CJ, Kopecky SL, Kleiman NS, Pacchiana CM, Berdan LG, Kitt MM, Simoons ML, Topol EJ. Management of patients with acute coronary syndromes in the United States by platelet glycoprotein IIb/IIIa inhibition. Insights from the platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial. Circulation. 2000 Sep 5; 102(10):1093-100.
    View PubMed
  123. Allison TG, Farkouh ME, Smars PA, Evans RW, Squires RW, Gabriel SE, Kopecky SL, Gibbons RJ, Reeder GS. Management of coronary risk factors by registered nurses versus usual care in patients with unstable angina pectoris (a chest pain evaluation in the emergency room [CHEER] substudy). Am J Cardiol. 2000 Jul 15; 86 (2):133-8
    View PubMed
  124. Liuzzo G, Goronzy JJ, Yang H, Kopecky SL, Holmes DR, Holmes DR, Frye RL, Weyand CM. Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. Circulation. 2000 Jun 27; 101 (25):2883-8
    View PubMed
  125. Wright RS, Monnahan RL, Kopecky SL, Jones CT, Holmes DR Jr, Holmes DR Jr. Cardiac catheterization reduces resource utilization in patients with chronic chest pain. Catheter Cardiovasc Interv. 2000 Apr; 49 (4):363-6
    View PubMed
  126. Gussak I, Chaitman BR, Kopecky SL, Nerbonne JM. Rapid ventricular repolarization in rodents: electrocardiographic manifestations, molecular mechanisms, and clinical insights. J Electrocardiol. 2000 Apr; 33 (2):159-70
    View PubMed
  127. Sgura FA, Kopecky SL, Grill JP, Gibbons RJ. Supine exercise capacity identifies patients at low risk for perioperative cardiovascular events and predicts long-term survival. Am J Med. 2000 Mar; 108 (4):334-6
    View PubMed
  128. Roger VL, Farkouh ME, Weston SA, Reeder GS, Jacobsen SJ, Zinsmeister AR, Yawn BP, Kopecky SL, Gabriel SE. Sex differences in evaluation and outcome of unstable angina. JAMA. 2000 Feb 2; 283 (5):646-52
    View PubMed
  129. Gussak I, Wright RS, Kopecky SL, Hammill SC. Exercise-induced ST segment elevation in Q wave leads in postinfarction patients: defining its meaning and utility in today's practice. Cardiology. 2000; 93(4):205-9.
    View PubMed
  130. Gussak I, Brugada P, Brugada J, Wright RS, Kopecky SL, Chaitman BR, Bjerregaard P. Idiopathic short QT interval: a new clinical syndrome? Cardiology. 2000; 94 (2):99-102
    View PubMed
  131. Gussak I, Wright RS, Bjerregaard P, Chaitman BR, Zhou SH, Hammill SC, Kopecky SL. False-negative and false-positive ECG diagnoses of Q wave myocardial infarction in the presence of right bundle-branch block. Cardiology. 2000; 94 (3):165-72
    View PubMed
  132. Liuzzo G, Kopecky SL, Frye RL, O'Fallon WM, Maseri A, Goronzy JJ, Weyand CM. Perturbation of the T-cell repertoire in patients with unstable angina. Circulation. 1999 Nov 23; 100 (21):2135-9
    View PubMed
  133. Kopecky SL. Treatment of Acute MI. Institute for Clinical Systems Improvement. Postgraduate Medicine. 1999 Nov; 106(6):57-58.
  134. Handa N, Schaff HV, Morris JJ, Anderson BJ, Kopecky SL, Enriquez-Sarano M. Outcome of valve repair and the Cox maze procedure for mitral regurgitation and associated atrial fibrillation. J Thorac Cardiovasc Surg. 1999 Oct; 118(4):628-35.
    View PubMed
  135. Daly R, Ebling W, Pieniaszek H, Cain V, Kopecky S, Murphy J. Roxifiban, a new oral IIb/IIIa glycoprotein receptor antagonist, in patients with coronary artery disease. Lancet. 1999 Jun 26; 353(Suppl 3):49.
    View PubMed
  136. Kopecky SL, Gersh BJ, McGoon MD, Chu CP, Ilstrup DM, Chesebro JH, Whisnant JP. Lone atrial fibrillation in elderly persons: a marker for cardiovascular risk. Arch Intern Med. 1999 May 24; 159 (10):1118-22
    View PubMed
  137. Kopecky SL. Idiopathic atrial fibrillation: prevalence, course, treatment, and prognosis. J Thromb Thrombolysis. 1999 Jan; 7 (1):27-31
    View PubMed
  138. Farkouh ME, Smars PA, Reeder GS, Zinsmeister AR, Evans RW, Meloy TD, Kopecky SL, Allen M, Allison TG, Gibbons RJ, Gabriel SE. Clinical trial of a chest-pain observation unit for patients with unstable angina. N Engl J Med. 1998 Dec 24; 339(26):1882-1888.
    View PubMed
  139. Blackshear JL, Kopecky SL, Litin SC, Safford RE, Hammill SC. Management of atrial fibrillation in adults: prevention of thromboembolism and symptomatic treatment. Mayo Clin Proc. 1996 Feb; 71 (2):150-60
    View PubMed
  140. Wright RS, Kopecky SL, Nishimura RA. Echocardiography in acute myocardial infarction. ACC Current Journal Review. 1996; 5(6):24-27.
  141. Wright RS, Kopecky SL. Streptokinase: a review. P T. 1995; 20(11 Suppl):4s-11s.
  142. Reeder GS, Kopecky SL. Thrombolysis in acute myocardial infarction: t-PA for everyone? Mayo Clin Proc. 1994 Aug; 69 (8):796-9
    View PubMed
  143. McBride MO, Coker RJ, Horner PJ, Chesebro JH, Wiebers DO, Weston R, Weber JN, Bardsley WT, Kopecky SL, Litin SC, Meissner I, Zerbe DM. Diarrhoea associated with Clostridium difficile in AIDS patients receiving rifabutin. Lancet 1994 Feb 12; 343 (8894):417
    View PubMed
  144. Zhu WX, Oh JK, Kopecky SL, Schaff HV, Tajik AJ. Mitral regurgitation due to ruptured chordae tendineae in patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 1992 Jul; 20 (1):242-7
    View PubMed
  145. Kopecky SL. Management decisions in lone atrial fibrillation. Hosp Pract (Off Ed). 1992 Jun 15; 27 (6):135-8, 143, 147-50
    View PubMed
  146. Kopecky SL. The role of anticoagulation in atrial fibrillation. Cardio 87-97. 1990; 0: 0.
  147. Kopecky SL, Gersh BJ, McGoon MD, Mair DD, Porter CJ, Ilstrup DM, McGoon DC, Kirklin JW, Danielson GK. Long-term outcome of patients undergoing surgical repair of isolated pulmonary valve stenosis. Follow-up at 20-30 years. Circulation. 1988 Nov; 78 (5 Pt 1):1150-6
    View PubMed
  148. Kopecky SL, Gersh BJ. Dilated cardiomyopathy and myocarditis: natural history, etiology, clinical manifestations, and management. Curr Probl Cardiol. 1987 Oct; 12 (10):569-647
    View PubMed
  149. Kopecky SL, Gersh BJ, McGoon MD, Whisnant JP, Holmes DR, Ilstrup DM, Frye RL. The natural history of lone atrial fibrillation. A population-based study over three decades. N Engl J Med. 1987 Sep 10; 317(11):669-74.
    View PubMed
  150. Kopecky SL, Callahan JA, Tajik AJ, Seward JB. Percutaneous pericardial catheter drainage: report of 42 consecutive cases. Am J Cardiol. 1986 Sep 15; 58(7):633-5.
    View PubMed
  151. Kopecky SL. Pneumomediastinum: pitfalls in diagnosis and management. Minn Med. 1984 Dec; 67(12):683-4.
    View PubMed
  152. Kopecky SL. Effects of methylprednisolone sodium succinate on experimental noncardiogenic pulmonary edema. Intensive Care Med. 1981; 7:121-124.
    View PubMed